Right therapy.
Right patient.
Right time.

NeuroFirst™ Memory

A new earlier-detection blood test to assess memory complaints for people over 60

Right therapy.
Right patient.
Right time.

NeuroFirst™ Memory

A new earlier-detection blood test to assess memory complaints for people over 60

Cx Precision Medicine technology enables physicians at the primary care level to more accurately diagnose neurodegenerative disorders such as Alzheimer’s Dementia and Parkinson’s Disease, leading to earlier, targeted treatments for patients.

Cx Precision Medicine is Dedicated to Changing Expectations

The revolutionary NeuroFirstTM  Memory test from Cx Precision Medicine is a simple blood test for people who are 60 and up that can help primary care physicians rule out dementia and differentiate between those patients who would benefit from further neurological testing and those whose symptoms are very unlikely to be caused by Alzheimer’s Dementia, resulting in peace of mind and better outcomes at lower costs.

Evidence Based Precision Medicine

A New Approach for Targeted Intervention

Our technology combines proteomics and artificial intelligence to drive the results of our tests. We measure a large number of proteins in blood then use our sophisticated algorithms, trained on thousands of samples, to drive the results.

Coming Soon

NeuroFirst™ Parkinson's test will help primary care physicians with the challenge of identifying patients who should be further evaluated for Parkinson's Disease